Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nexomics Biosciences logo — Nexomics offers comprehensive range of gene-to- structure se...

Nexomics Biosciences

Nexomics offers comprehensive range of gene-to- structure services to the biopharmaceutical community.

Founded 2007 United States Rocky Hill, United States 10 employees Biopharma, Biotechnology +1

General Information

Company Name Nexomics Biosciences
Founded Year 2007
Location United States Rocky Hill, United States +1
Employees 10
Industries Biopharma, Biotechnology, Clean Energy
Social

Get notified when Nexomics Biosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Nexomics Biosciences

Nexomics Biosciences is a biopharmaceutical company established in 2007 with a focus on the discovery, development, and commercialization of novel drugs in the areas of cancer, antiviral, and antibiotic treatments. The company operates as a contract research organization (CRO), offering a wide range of gene-to-structure services to the biopharmaceutical community. Their services encompass bioinformatics target profiling, gene cloning, recombinant protein expression, laboratory-scale fermentation, crystallization, NMR structural studies, X-ray crystallography structural studies, assay development, and functional annotation. Nexomics Biosciences aims to create a portfolio of intellectual property associated with structure-based assay development, protein production, and drug discovery. Their long-term objective is the development of a proprietary pharmaceutical discovery program based on characterizing disease-related proteins and their molecular functions, and identifying potential drug target binding compounds. The company operates within the Biopharma, Biotechnology, and Clean Energy industries, positioning itself at the intersection of health and sustainability. To the venture capital community, Nexomics Biosciences presents a compelling opportunity to invest in a company that is at the forefront of innovative drug discovery and development. With its comprehensive range of gene-to-structure services and an ambitious goal of building a robust intellectual property portfolio, Nexomics Biosciences has the potential to play a significant role in shaping the future of pharmaceutical advancements.

Taxonomy: biopharmaceutical research, gene-to-structure services, drug discovery, protein production, assay development, bioinformatics analysis

No funding data available for Nexomics Biosciences yet.

Get notified when Nexomics Biosciences raises funding

Nexomics Biosciences Alternatives & Competitors

Nexomics Biosciences vs
NanoImaging Services
NanoImaging Services United States

Cryo-EM for Drug Discovery. Gene-to-Structure, Structural Biology, Nanoparticle Characterization on...

Unknown
40 employees
Biotechnology, Pharmaceutical
Compare Nexomics Biosciences vs NanoImaging Services
Nexomics Biosciences vs
Peak Proteins – a Sygnature Discovery Business
Peak Proteins – a Sygnature Discovery Business United Kingdom

Peak Proteins (part of Sygnature Discovery Ltd) combines a deep knowledge of protein science with st...

39 employees
Biotechnology
Nexomics Biosciences vs
ZoBio
ZoBio

The Integrated Fragment Discovery Engine

44 employees
Biotechnology, Health Care
Also compare with: Nexomics Biosciences vs Immuto Scientific Immuto Scientific

FAQ About Nexomics Biosciences

Nexomics offers comprehensive range of gene-to- structure services to the biopharmaceutical community.
Nexomics Biosciences was founded in 2007.
Nexomics Biosciences is headquartered in Rocky Hill, United States.
Nexomics Biosciences operates in the following industries: Biopharma, Biotechnology, Clean Energy.
Nexomics Biosciences has approximately 10 employees.
Top alternatives and competitors to Nexomics Biosciences include NanoImaging Services, Peak Proteins – a Sygnature Discovery Business, ZoBio, Immuto Scientific, Shamrock Structures, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nexomics Biosciences and NanoImaging Services are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nexomics Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy